![](https://emeatribune.com/wp-content/uploads/2024/04/stocks-making-the-biggest-moves-midday-globe-life-jpmorgan-zoetis-wells-fargo-and-more-980x653.jpg)
![](https://image.cnbcfm.com/api/v1/image/105743398-1550267415237img_3356.jpg?v=1550267639&w=1920&h=1080)
Check out the companies making headlines in midday trading. JPMorgan — The bank fell 5% after disclosing that its net interest income level could fall short of Wall Street analysts’ expectations in 2024, despite beating both top- and bottom-line estimates in its last quarter. CEO Jamie Dimon also underscored the danger of inflationary pressures. Wells Fargo — Shares of the bank inched lower by less than 1% after it reported a decline in net interest income during the first quarter. Wells Fargo did beat analyst expectations for its first-quarter adjusted earnings and revenue. BlackRock — Shares of BlackRock fell nearly 2%. The asset manager reported total net inflows that came in below expectations, per StreetAccount. BlackRock posted first-quarter adjusted earnings of $9.81 per share on $4.73 billion of revenue, higher than the $9.35 per share on revenue of $4.68 billion that analysts polled by LSEG had forecasted. Globe Life — The life insurance stock bounced 10% after plummeting more than 50% during Thursday’s session. The slide was induced by a report from Fuzzy Panda Research , where the firm disclosed a short position in the stock and made allegations of insurance fraud. Paramount — The entertainment company slipped nearly 2% after disclosing plans to reduce its board to seven directors from 11. Paramount is currently in talks of a merger with Skydance Media. Corteva — The agriculture chemical stock lost 3.8% after JPMorgan downgraded it to neutral from overweight. The firm said shares were not worth purchasing ahead of the first quarter earnings report, given the weakness expected. Ciena — Shares slipped nearly 3% after Citi initiated coverage of the software company with a sell rating. The bank said that investors are too optimistic about the potential artificial intelligence tailwind, which is further out than they expect. Zoetis — The pet medication company sank more than 7%. The decline came after a report from The Wall Street Journal that looked into potential side effects from Zoetis’s arthritis drugs Librela and Solensia. Arista Networks — Shares dropped 9% following a double downgrade at Rosenblatt to sell from buy. The firm warned Arista’s artificial-intelligence opportunity may be smaller than expected. — CNBC’s Michelle Fox, Alex Harring, Tanaya Macheel and Pia Singh contributed reporting.
EMEA Tribune is not involved in this news article, it is taken from our partners and or from the News Agencies. Copyright and Credit go to the News Agencies, email news@emeatribune.com Follow our WhatsApp verified Channel